2015-2019 Growth Strategies in the US Hemostasis Testing Market for Instrument and Reagent Suppliers
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib. , Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis- Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles ofmajor suppliers and emerging market entrants.
Market Segmentation Analysis
Comprehensive marketsegmentation analysis, including:
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. The report explores business and technological trends in the US coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib. , Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis- Sales and market shares of major instrument and reagent suppliers.
Competitive Assessments
Extensive strategic profiles ofmajor suppliers and emerging market entrants.
Market Segmentation Analysis
Comprehensive marketsegmentation analysis, including:
- Hospitals
- Commercial/Private Laboratories
- Physician Offices
- Test volume forecasts for over 40 major proceduresby market segment.
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Coagulation Tests
1. INTRODUCTION
2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
3. ALPHA-2 ANTIPLASMIN
4. ANTITHROMBIN III
5. BLEEDING TIME
6. D-DIMER
7. ETHANOL FLOCCULATION TEST
8. EUGLOBULIN LYSIS
9. FACTOR ASSAYS
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. FIBRIN DEGRADATION PRODUCTS
11. FIBRINOGEN
12. HEPARIN
13. HIRUDIN
14. HYPERCOAGULABILITY AND THROMBOSIS
15. LIPOPROTEIN A
16. PLASMIN
17. PLASMINOGEN
18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
19. PLATELET FUNCTION TESTS
20. PLATELET AGGREGATION
21. PROTEINS C AND S
22. PROTHROMBIN FRAGMENT 1.2
23. PROTHROMBIN TIME (PT)
24. REPTILASE TIME
25. THROMBIN TIME
26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)
27. VON WILLEBRAND'S FACTOR
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. CHROMOGENIC SUBSTRATES
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MOLECULAR DIAGNOSTICS
5. MICROCOMPUTERS
6. AUTOMATION
7. ROBOTICS
8. ARTIFICIAL INTELLIGENCE
9. DRY CHEMISTRY
10. BIOSENSORS
III. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares
X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XII. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Coagulation Tests
1. INTRODUCTION
2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
3. ALPHA-2 ANTIPLASMIN
4. ANTITHROMBIN III
5. BLEEDING TIME
6. D-DIMER
7. ETHANOL FLOCCULATION TEST
8. EUGLOBULIN LYSIS
9. FACTOR ASSAYS
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. FIBRIN DEGRADATION PRODUCTS
11. FIBRINOGEN
12. HEPARIN
13. HIRUDIN
14. HYPERCOAGULABILITY AND THROMBOSIS
15. LIPOPROTEIN A
16. PLASMIN
17. PLASMINOGEN
18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
19. PLATELET FUNCTION TESTS
20. PLATELET AGGREGATION
21. PROTEINS C AND S
22. PROTHROMBIN FRAGMENT 1.2
23. PROTHROMBIN TIME (PT)
24. REPTILASE TIME
25. THROMBIN TIME
26. TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA)
27. VON WILLEBRAND'S FACTOR
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their Potential Applications
1. CHROMOGENIC SUBSTRATES
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MOLECULAR DIAGNOSTICS
5. MICROCOMPUTERS
6. AUTOMATION
7. ROBOTICS
8. ARTIFICIAL INTELLIGENCE
9. DRY CHEMISTRY
10. BIOSENSORS
III. U.S.A.
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares
X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
XI. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
XII. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere
LIST OF TABLES
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category
U.S.A., Laboratories Performing Coagulation Tests By Market Segment
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Commercial/Private Laboratories Average Daily Test Volume
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Coagulation Test Volume By Market Segment
U.S.A., All Market Segments Coagulation Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume
U.S.A., Commercial/Private Laboratories Coagulation Test Volume
U.S.A., Physician Offices/Group Practices Coagulation Test Volume
U.S.A., Coagulation Reagent Market By Market Segment
U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
U.S.A., Coagulation Instrument Market By Market Segment
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
U.S.A., Total Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing D-dimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's Factor Tests
Executive Summary Table: U.S.A., Total Coagulation Diagnostics Market By Market Segment and Product Category
U.S.A., Laboratories Performing Coagulation Tests By Market Segment
U.S.A., Hospital Laboratories Performing Coagulation Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing Coagulation Tests By Annual Test Volume
U.S.A., Hospital Laboratories Average Daily Test Volume
U.S.A., Commercial/Private Laboratories Average Daily Test Volume
U.S.A., Physician Offices/Group Practices Average Daily Test Volume
U.S.A., Total Coagulation Test Volume By Market Segment
U.S.A., All Market Segments Coagulation Test Volume
U.S.A., Hospital Laboratories Coagulation Test Volume
U.S.A., Commercial/Private Laboratories Coagulation Test Volume
U.S.A., Physician Offices/Group Practices Coagulation Test Volume
U.S.A., Coagulation Reagent Market By Market Segment
U.S.A., Major Suppliers of Coagulation Reagents Estimated Sales and Market Shares
U.S.A., Coagulation Instrument Market By Market Segment
U.S.A., Major Suppliers of Coagulation Analyzers, Estimated Instrument Sales and Market Shares
U.S.A., Total Coagulation Diagnostics Market By Product Category
U.S.A., Major Suppliers of Coagulation Diagnostic Products, Estimated Sales and Market Shares